Home > NRC Library > ADAMS Public Documents

06-27843-02 610062 Bristol-Myers Squibb PRI (Term.)

Accession Number: ML18276A245

Date Released: Monday, December 17, 2018

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML18276A246 - Bristol-Myers Squibb PRI, Termination Request Letter dtd September 26, 2018. (247 page(s), 9/26/2018)
• ML18324A784 - Bristol-Myers Squibb PRI, Request for Additional Information Ltr. Dated 11/8/18, Rec'd in LAT on 11/14/18. (1 page(s), 9/26/2018)
• ML18324A788 - Bristol-Myers Squibb PRI, Deficiency Response e-mail dated 11/13/18. (3 page(s), 11/13/2018)
• ML18325A052 - Bristol-Myers Squibb PRI, Final Status Decontamination & Decommissioning Survey Report dtd 9/6/18. (234 page(s), 8/6/2018)
• ML18332A264 - Bristol-Myers Squibb PRI, Radioative Package Receipt Confirmation E-mail dtd November 19, 2018, Control No. 610062. (3 page(s), 11/19/2018)
• ML18341A149 - Bristol-Myers Squibb PRI, Cover Letter dtd November 28, 2018, for License Termination, License Amendment No. 24, Control No. 610062. (3 page(s), 11/28/2018)
• ML18341A151 - Bristol-Myers Squibb PRI, License Termination, License Amendment No. 24, Control No. 610062. (1 page(s), 11/28/2018)